American Journal of Neuroradiology, Vol 18, Issue 4 639-645, Copyright © 1997 by American Society of Neuroradiology
ARTICLES |
Direct endovascular thrombolytic therapy for dural sinus thrombosis: infusion of alteplase
SY Kim and JH Suh
Department of Diagnostic Radiology, Ajou University, School of Medicine, Suwon, Korea.
PURPOSE: To evaluate the efficacy, safety, and results of direct thrombolytic therapy in intracranial dural sinus thrombosis by infusion of alteplase (recombinant tissue plasminogen activator). METHODS: Nine patients were treated during a 2-year period for intracranial dural sinus thrombosis. A microcatheter was placed directly into the thrombus in the dural sinus via the transfemoral route. Thrombolysis was initiated with a rapid injection of 10 mg of alteplase over 10 minutes, followed in 3 hours by a continuous infusion of 50 mg, then a continuous infusion at 5 mg per hour until complete thrombolysis or a total dose of 100 mg per day had been reached. Repeat thrombolysis was tried the following day if complete recanalization did not occur at 100 mg per day. RESULTS: Successful recanalization with improvement of symptoms was achieved in all cases. Time required for complete thrombolysis was between 8 and 43 hours. The total dose of alteplase ranged from 50 to 300 mg. Complications of a small intrapelvic hemorrhage and oozing at a femoral puncture site occurred in separate cases, but were not related to the amount of infused alteplase. MR venograms obtained 1 to 4 weeks after the procedure showed no evidence of reocclusion of the dural sinuses. CONCLUSION: Direct fibrinolytic therapy with alteplase is safe, fast, and effective in treating dural sinus thrombosis. However, to prevent hemorrhagic complications, further studies are required to determine its optimal dose and proper rate of administration.
This article has been cited by other articles:
![]() |
D.V. La Barge III, F.S. Bishop, E.A. Stevens, R. Eskandari, R.H. Schmidt, E.J. Skalabrin, and P.P. Ng Intrasinus Catheter-Directed Heparin Infusion in the Treatment of Dural Venous Sinus Thrombosis AJNR Am. J. Neuroradiol., October 1, 2009; 30(9): 1672 - 1678. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wasay and A. K. Kamal Anticoagulation in Cerebral Venous Sinus Thrombosis: Are We Treating Ourselves? Arch Neurol, July 1, 2008; 65(7): 985 - 987. [Full Text] [PDF] |
||||
![]() |
J. Stam, C. B.L.M. Majoie, O. M. van Delden, K. P. van Lienden, and J. A. Reekers Endovascular Thrombectomy and Thrombolysis for Severe Cerebral Sinus Thrombosis: A Prospective Study Stroke, May 1, 2008; 39(5): 1487 - 1490. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Stolz, T. Gerriets, R. H. Bodeker, M. Hugens-Penzel, and M. Kaps Intracranial Venous Hemodynamics Is a Factor Related to a Favorable Outcome in Cerebral Venous Thrombosis Stroke, June 1, 2002; 33(6): 1645 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kimber Cerebral venous sinus thrombosis QJM, March 1, 2002; 95(3): 137 - 142. [Full Text] [PDF] |
||||
![]() |
M. Wasay, R. Bakshi, S. Kojan, G. Bobustuc, N. Dubey, D.H. Unwin, P. Gates, and R. Gerraty Nonrandomized Comparison of Local Urokinase Thrombolysis Versus Systemic Heparin Anticoagulation for Superior Sagittal Sinus Thrombosis Editorial Comment Stroke, October 1, 2001; 32(10): 2310 - 2317. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liang, Y. Korogi, T. Sugahara, M. Onomichi, Y. Shigematsu, D. Yang, M. Kitajima, Y. Hiai, and M. Takahashi Evaluation of the Intracranial Dural Sinuses with a 3D Contrast-enhanced MP-RAGE Sequence: Prospective Comparison with 2D-TOF MR Venography and Digital Subtraction Angiography AJNR Am. J. Neuroradiol., March 1, 2001; 22(3): 481 - 492. [Abstract] [Full Text] |
||||
![]() |
S F T M de Bruijn, R J de Haan, and J Stam Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients J. Neurol. Neurosurg. Psychiatry, January 1, 2001; 70(1): 105 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
H T S BENAMER and I BONE Cerebral venous thrombosis: anticoagulants or thrombolyic therapy? J. Neurol. Neurosurg. Psychiatry, October 1, 2000; 69(4): 427 - 430. [Full Text] [PDF] |
||||
![]() |
K. Chow, Y. P. Gobin, J. Saver, C. Kidwell, P. Dong, and F. Vinuela Endovascular Treatment of Dural Sinus Thrombosis With Rheolytic Thrombectomy and Intra-Arterial Thrombolysis Stroke, June 1, 2000; 31(6): 1420 - 1425. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Allroggen and R. J Abbott Cerebral venous sinus thrombosis Postgrad. Med. J., January 1, 2000; 76(891): 12 - 15. [Abstract] [Full Text] |
||||
![]() |
M.-G. Bousser Cerebral Venous Thrombosis : Nothing, Heparin, or Local Thrombolysis? Stroke, March 1, 1999; 30(3): 481 - 483. [Full Text] [PDF] |
||||
![]() |
J. L. Frey, G. J. Muro, C. G. McDougall, B. L. Dean, and H. K. Jahnke Cerebral Venous Thrombosis : Combined Intrathrombus rtPA and Intravenous Heparin Stroke, March 1, 1999; 30(3): 489 - 494. [Abstract] [Full Text] [PDF] |
||||





